QURE Competitors & Alternatives
Compare Uniqure NV with similar stocks in the same industry
Biotechnology
QURE
Main Stock$48.85
Tradestie Score
63
Market Cap
$3.39B
Revenue Growth
1.3%
Analyst Upside
+19.7%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SRRK
Scholar Rock Holding Corporation Common Stock
|
$52.33
|
$3.33B | - | 63 | Compare |
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$32.63
|
$3.31B | - | 60 | Compare |
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 49 | Compare |
|
MLYS
Mineralys Therapeutics, Inc. Common Stock
|
$25.78
|
$3.09B | - | 57 | Compare |
|
VKTX
Viking Therapeutics, Inc
|
$37.87
|
$3.08B | - | 60 | Compare |
|
CNTA
Centessa Pharmaceuticals plc American Depositary Shares
|
$40.50
|
$3.03B | - | 61 | Compare |
|
XENE
Xenon Pharmaceuticals Inc
|
$55.58
|
$3.02B | - | 67 | Compare |
|
CGON
CG Oncology, Inc. Common stock
|
$68.72
|
$3.01B | - | 63 | Compare |
|
APLS
Apellis Pharmaceuticals, Inc. Common Stock
|
$41.03
|
$2.92B | 38.3 | 59 | Compare |
|
RARE
Ultragenyx Pharmaceutical Inc.
|
$29.11
|
$2.89B | - | 59 | Compare |
More QURE Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry